Quality

Our Quality Approach Entails:

  • Ensuring customer satisfaction by producing accurate, quality, and reliable products on time.
  • Supporting the continuous improvement of employees in order to work with qualified human resources and lay the foundations of a learning organization.
  • To comply with all legal requirements while developing the product.
  • Using the most reliable, high-quality raw materials.
  • To have production facilities that will manufacture in accordance with GMP and ISO 22000: 2018 Food Safety Management System, ISO 9001: 2015 Quality Management System and Halal Certificate standards.
  • Using the latest modern technology.
  • To control every stage, from the supply of raw materials to the delivery of the product to the end customer.
  • To make production in accordance with the nutrient contents and dosages included in the license and product label information, and having its suitability tested in an internationally recognized accredited laboratory when necessary.
  • Regularly auditing and reviewing our quality system to monitor its adequacy, appropriateness, and effectiveness.
  • To continuously improve our quality system.

Production Facility

Our production facility is designed in accordance with GMP and ISO 22000: 2018 food safety standards to ensure we are consistently producing high-quality products.

In addition to the principle of one-way personnel and material flow, critical production and storage areas are monitored and recorded 24 hours a day through the automation system. GMP protocols are based on all stages of production and storage.

Our products are developed to meet international standards with an innovative approach in formulation design, raw material, and packaging materials selection at the R&D stage and are monitored and analyzed at every stage of production.

 

Solid Form Production Department has the following capacity.

Tablet: 1,250 billion pieces / year

Capsule: 210 million pcs / year

Softgel: 650 million pieces / year

Sachet: 50 million pieces / year


The Liquid Form Production Department has a capacity of 32 million / year.


Production Forms

Tablet Form

  1. Tablet
  2. Film tablet
  3. Effervescent tablet
  • The ability to directly produce products in the appropriate color, size, and shape
  • Ability to produce products that are easy to drink because of their pleasant odor and taste characteristics
  • Option to produce standard and effervescent products
  • Film coating option
  • High stability against temperature, humidity, and light
  • Controlled processes ensuring product quality safety and continuity

Capsule Form

For Capsules:

  • Ability to directly produce products in appropriate color, size and shape
  • High stability
  • High component stability
  • Film gelatin and vegetarian capsule usage option
  • Controlled processes ensuring product quality, safety, and continuity

For Softgel Capsules:

  • Ability to directly produce products in appropriate color, size and shape
  • High-quality components
  • Production flexibility to produce complex formulations
  • Increased efficiency and absorption
  • High bioavailability
  • Protection against oxidation and degradation
  • Ensuring product uniformity
  • Controlled processes ensuring product quality safety and continuity

Sachet Form

  • Ability to directly manufacture products with appropriate color and transparency
  • Ability to manufacture products that dissolve quickly and are easy to drink because of its pleasant odor and taste characteristics
  • High stability against temperature, humidity, and light
  • Controlled processes ensuring product quality safety and continuity

Liquid Form

  1. Solution
  2. Suspension
  • Fast-absorbing products
  • High stability against temperature, humidity and light
  • Ability to produce products that are easy to drink with odor and taste characteristics
  • Ensuring product uniformity
  • Controlled processes ensuring product quality safety and continuity

Bioresearch Center 

Our Bioresearch Center is a single location with a total of 915 m², including 203 m² of office space and 712 m² of laboratory space. It has been specially designed for technical personnel to carry out appropriate workspaces and research activities.

Our Bioresearch Center’s R&D strategies are based on three pillars:

  • To scientifically examine natural products that have traditional uses as old as the history of humanity, and to develop them with modern medicine. 
  • To focus on potential innovative products by identifying humanity’s future needs
  • To develop innovative raw materials through its extensive biotechnology infrastructure and knowledge base while constantly working to improve

Our R&D studies on domestic probiotic production from breast milk, which we started in 2017, continue at full speed. We are investigating the adhesion of our probiotics obtained from breast milk to the intestines and their effects on colon cancer. The scaling studies of our probiotic bacteria obtained from breast milk are carried out at the Bioresearch Center Probiotic Pilot Facility, where our 0.3-3-30 and 300L reactors are located. We have reached the final stage of scaling studies of our Lactobacillus rhamnosus NBC 14 strain in our pilot facility. We are happy to add a new member to our probiotics ready for industrial production.

Quality Control Laboratories

Our finished products are tested by a team of experts in our fully equipped chemical and microbiological laboratories at every stage of production, starting from raw materials and packaging to the pure water used in production to ensure international standards as well as product quality, safety, and continuity. In process control, specialists perform control by taking samples at every stage of production.

Storage

All raw and packaging materials that come to our facility are stored in our temperature-controlled automation system.

All raw and packaging materials are tested in our fully equipped chemical and microbiological laboratories in accordance with international testing standards.

Environmental Awareness

With the contribution of our employees in our production facility, all of our waste is classified in accordance with regulations and recycled with a zero waste approach.

It has been designed in accordance with international standards, has a validated ventilation system, an efficient pure water system, and complies with Good Manufacturing Practices, ISO 22000:2018 Food Safety standards.

R&D

Our facility works under the supervision of expert scientists who understand excellence in research and development activities. Our development teams working in our facilities often participate in joint projects in cooperation with scientists and universities in different countries of the world. In this way, developments in different countries are followed simultaneously.

While developing our products, we consider cost optimization while also seeking to meet our goal of creating value. We consider it our duty to offer our users natural and quality products at affordable prices.

Our R&D strategies:

Formulation development

All of our formulations are designed with a scientific approach by our expert researchers in our R&D laboratories. Product-quality assurance and continuity are guaranteed within the framework of IFOS, GMP, WHO, and GOED standards. Our production areas are equipped with the latest in advanced technology, and our product quality and safety are continuously monitored by an automated system while going through the production line.

Technology development

We carefully examine natural products, whose traditional use  is as old as human history, in preventive treatment, and we develop them using the latest research in modern medicine.

We develop innovative raw materials with our extensive biotechnology infrastructure and knowledge base that we work hard to continuously develop.